Active, Not Recruiting
NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer
NCT03789110
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
- University of Texas Southwestern Medical Center Dallas, Texas, United States